Melanoma Clinical Trials
Find clinical trials for melanoma. Search for melanoma clinical trials in different cities and states across the United States.
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefStereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
Sponsor:
Hamilton Health Sciences Corporation
Location:
Code:
NCT04177056
Conditions
Bone Metastases
Prostate Cancer
Breast Cancer
Renal Cell Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SBRT
BMS-986340, Nivolumab, DocetaxelA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT04895709
Conditions
Cervical Cancer
Gastric/Gastroesophageal Junction Adenocarcinoma
Microsatellite Stable Colorectal Cancer
Non-Small-Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986340
BMS-936558-01
Docetaxel
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT03941756
Conditions
Anatomic Stage III Breast Cancer AJCC v8
Breast Inflammatory Carcinoma
Locally Advanced Breast Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Indocyanine Green
Lymphangiography
Lymphovenous Bypass
CFT1946A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 As Monotherapy and Combination Therapy in Subjects with BRAF V600 Mutant Solid Tumors
Sponsor:
C4 Therapeutics, Inc.
Location:
Code:
NCT05668585
Conditions
Solid Tumors
Melanoma
NSCLC
CRC
ATC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CFT1946
Trametinib
Cetuximab
Observational StudyStorage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Sponsor:
Vanderbilt-Ingram Cancer Center
Location:
Code:
NCT01205815
Conditions
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tissue and blood collection
VET3-TGIA Study of VET3-TGI in Patients With Solid Tumors
Sponsor:
KaliVir Immunotherapeutics
Location:
Code:
NCT06444815
Conditions
Solid Tumor, Adult
Microsatellite Stable Colorectal Cancer
Head and Neck Squamous Cell Carcinoma
Cervical Cancer
Kidney Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
VET3-TGI
Pembrolizumab
Observational StudyCirculating Tumor DNA Exposure in Peripheral Blood
Sponsor:
Quantgene Inc.
Location:
Code:
NCT03517332
Conditions
Colorectal Cancer
Pancreatic Adenocarcinoma
Gastric Cancer
Hepatocellular Carcinoma
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Immune RecallA Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Sponsor:
Duke University
Location:
Code:
NCT05077137
Conditions
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tetanus Diptheria Vaccine
Polio Boost Immunization
PD-1/PD-L1 InhibitorEvaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Sponsor:
Jason J. Luke, MD
Location:
Code:
NCT04157985
Conditions
Advanced Solid Tumors
NSCLC
Bladder Cancer
HNSCC
Renal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Continue PD-1/PD-L1 Inhibitors treatment
Discontinue PD-1/PD-L1-1 inhibitor